Future Direction of Stem Cells in Cardiovascular Disease

Continuing Medical Education

Future Direction of Stem Cells - Symposium

(object placeholder)

Online registration is now closed;
you may attend subject to seating availability.

Future Direction
of Stem Cells in
Cardiovascular
Disease

Presented by
Texas Heart Institute

Saturday, March 13, 2010
9 a.m. to 12 noon

The Westin Peachtree
Atlanta, Georgia

This event is not part of the official ACC Annual Scientific Sessions and/or the ACC's Innovation in Intervention I2 Summit in Partnership with the Cardiovascular Research Foundation as planned by their Program Committee.

Overview

The study of adult stem cells and their role in treating cardiovascular disease is quickly becoming an acceptable mode of treatment. The challenge remains to identify the very best types of stem cells, refine our delivery techniques, and establish the most effective doses of stem cells.

Target Audience
Cardiologists desiring to further their knowledge of how stem cells play a role in heart failure, acute myocardial infarction, and peripheral vascular disease will find the discussions timely and relevant to their practice in providing improved patient care.

The goal of this symposium is to educate physicians on the clinical application of stem cells in cardiovascular disease.

Learning Objectives
At the conclusion of this symposium, participants should be able to–

Summarize recent scientific advances related to the use of stem cells in treating heart failure, acute myocardial infarction and peripheral vascular disease.
Describe the mechanism of action of cell therapy in the treatment of cardiovascular disease.
Discuss the use of stem cells in the regeneration of damaged heart tissues.

Program

Saturday March 13, 2010

9:00 a.m. Welcome and Introduction
James T. Willerson, MD

9:05 a.m.   Stem Cells in Cardiovascular Disease:
                   Where Are We Today?
                James T. Willerson, MD

9:25 a.m.   Cell Therapy of Acute ST Elevation
                    Myocardial Infarction
                Andreas M. Zeiher, MD

9:45 a.m. Adult Stem Cells for Cardiac Repair
James T. Willerson, MD

10:05 a.m. Break

10:20 a.m. Case from Texas Heart Institute
Emerson C. Perin, MD, PhD

10:40 a.m.   Stem Cell Transplantation for
                    Ischemic Cardiomyopathy
                 James T. Willerson, MD

11:00 a.m.  Cells for the Treatment, Prevention and
                    Cure of Cardiovascular Disease
                 Kenneth R. Chien, MD, PhD

11:20 a.m.  Cell Therapy for Microvascular Repair
                     in Ischemic Tissue
                 Douglas W. Losordo, MD

11:40 a.m. Question and Answer Session

12:00 noon Adjourn

Program Director

James T. Willerson, MD
President and Medical Director
Texas Heart Institute at
St. Luke's Episcopal Hospital

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

An evaluation form will provide each participant the opportunity to review the speakers and their presentations, to identify educational needs, and to comment on any perceived commercial or promotional bias in the presentation.

Meeting Site

The symposium will be held at The Westin Peachtree in Atlanta, Georgia. The hotel's address is 210 Peachtree Street.
Phone: 404-659-1400.

Cancellation Policy
The Texas Heart Institute reserves the right to cancel the symposium if enrollment is deemed insufficient.

Registration

There is no registration fee, but pre-registration is required as seating is limited.

Online registration is now closed; you may attend subject to seating availability.

U.S. NEWS America's Best Hospitals 2011-12